501
Participants
Start Date
August 25, 2017
Primary Completion Date
September 25, 2018
Study Completion Date
November 30, 2018
Oral Levonadifloxacin/Linezolid Tablet
oral levonadifloxacin (1000 mg BID) or oral linezolid (600 mg BID)
Intravenous Levonadifloxacin/Linezolid Infusion
IV levonadifloxacin (800 mg BID) or IV linezolid (600 mg BID)
Om Surgical & Maternity Home, Varanasi
Popular Hospital, Varanasi
M.V. Hospital & Research Centre, Lucknow
KRM Hospital and Research Centre, Lucknow
S.R. Kalla Memorial Gastro & General Hospital, Jaipur
SMS Hospital, Jaipur
Marudhar Hospital, Jaipur
Sanjivani Superspeciality Hospital Pvt. Ltd., Ahmedabad
Medistar Multispeciality Hospital Pvt.Ltd., Himmatnagar
GMERS Medical College & General Hospital, Vadodara
Parul Institute of Medical Science, Vadodara
TNMC & BYL Nair Hospital, Mumbai
LTM Medical College and General Hospital, Mumbai
Deenanath Mangeshkar Hospital & Research Centre, Pune
Oyster & Pearl Hospital, Pune
Noble Hospital, Pune
Lifepoint Hospital, Pune
Ishwar Institute of Healthcare, Aurangabad
Government Medical College and Hospital, Nagpur
Shree Hospital & Critical Care Centre, Nagpur
Rahate Surgical Hospital, Nagpur
Cresent Hospital and Heart Centre, Nagpur
Indira Gandhi Government Medical College and Hospital, Nagpur
Datta Meghe Institute of Medical Sciences (Deemed University) Jawaharlal Nehru Medical College, Wardha
Osmania General Hospital, Hyderabad
Government General Hospital (Associated by Government Siddhartha Medical College), Vijayawada
Victoria Hospital, Bangalore
Mysore Medical College and Research Institute, Mysore
Vinaya Hospital and Research Centre, Mangalore
Ajanta Research Centre, Lucknow
Government Medical College, Kozhikode
B.J. Medical College and Sassoon General Hospital, Pune
Lead Sponsor
Wockhardt
INDUSTRY